<doc>
  <docmeta id="113s2549is">
    <bill congress="113" type="s" number="2549" version="is"/>
    <revision size="7801" annotations="0" status="complete" id="8" commit-time="2014-07-22T20:48:20Z" committer="mbohmer" doc="113s2549is/8.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public">
	<metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 S2549 IS: Safe and Affordable Drugs from Canada Act of 2014</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. Senate</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2014-06-26</dc:date>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>113th CONGRESS</congress>
    <session>2d Session</session>
		<legis-num>S. 2549</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20140626">June 26, 2014</action-date>
			<action-desc>
        <sponsor name-id="S311">Ms. Klobuchar</sponsor> (for herself and <cosponsor name-id="S197">Mr. McCain</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSHR00">Committee on Health, Education, Labor, and Pensions</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend the Federal Food, Drug, and Cosmetic Act to allow for the personal importation of safe and
			 affordable drugs from approved pharmacies in Canada.</official-title>
	</form>
	<legis-body>
		<section id="S1" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
			<text display-inline="no-display-inline">This Act may be cited as the
		  <quote>
          <short-title>
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Safe and Affordable Drugs from Canada Act of 2014" proposed="true">Safe and Affordable Drugs from Canada Act of 2014</cato:entity-ref>
          </short-title>
        </quote>.</text>
		</section>
    <section id="idD62F459942DF49B59FB3157554963F65">
      <enum>2.</enum>
      <header>Safe and affordable drugs from Canada</header>
      <text display-inline="no-display-inline">
        <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/ch:VIII">Chapter VIII of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/381">
          <cato:entity-ref entity-type="uscode" value="usc/21/381/etseq">21 U.S.C. 381 et seq.</cato:entity-ref>
        </external-xref>)</cato:entity> is amended by
			 adding at the end the following:</text>
      <quoted-block display-inline="no-display-inline" id="idf48230954e2043029ec94f5f5f54478e" style="OLC">
        <section id="id189b738c0cac476a9d2d54663246c60e">
          <enum>810.</enum>
          <header>Importation by individuals of prescription drugs from Canada</header>
          <subsection id="id33ce38dcf8e7430ab08fec11acfca021">
            <enum>(a)</enum>
            <header>In general</header>
            <text>Notwithstanding any other provision of this Act, not later than 180 days after the date of
			 enactment of this section, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall promulgate regulations
			 permitting individuals to safely import into the United States a
			 prescription drug described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:810/ss:b" proposed="true">subsection (b)</cato:entity-ref>.</text>
          </subsection>
          <subsection id="idF66486A9E01547EE9E748A42F77BF847">
            <enum>(b)</enum>
            <header>Prescription drug</header>
            <text>A prescription drug described in this subsection—</text>
            <paragraph id="id0DC9EA87C05B4E468E7FF626467560AA">
              <enum>(1)</enum>
              <text>is a prescription drug that—</text>
              <subparagraph id="id96bd01ac2b9145279c287e30d10bfeb4">
                <enum>(A)</enum>
                <text>is purchased from an approved Canadian pharmacy;</text>
              </subparagraph>
              <subparagraph id="idc29c4e47bbc4452da50ce5d837551c60">
                <enum>(B)</enum>
                <text>is dispensed by a pharmacist licensed to practice pharmacy and dispense prescription drugs in
			 Canada;</text>
              </subparagraph>
              <subparagraph id="idabb20122b0304ef2a37dad95b70dd0c5">
                <enum>(C)</enum>
                <text>is purchased for personal use by the individual, not for resale, in quantities that do not exceed a
			 90-day supply;</text>
              </subparagraph>
              <subparagraph id="id23541c8a98fe4aa7973afcc757b388bc">
                <enum>(D)</enum>
                <text>is filled using a valid prescription issued by a physician licensed to practice in a State in the
			 United States; and</text>
              </subparagraph>
              <subparagraph id="id6f615d8cdb584ac29ee7f68d4143928a">
                <enum>(E)</enum>
                <text>has the same active ingredient or ingredients, route of administration, dosage form, and strength
			 as a prescription drug approved by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/ch:V">chapter V</cato:entity-ref>; and</text>
              </subparagraph>
            </paragraph>
            <paragraph id="id080b371792344874bb271bf276133a32">
              <enum>(2)</enum>
              <text>does not include—</text>
              <subparagraph id="ida9f34eddf4b54d208f938b7c47dc8f6e">
                <enum>(A)</enum>
                <text>a controlled substance (as defined in <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                    <cato:entity-ref entity-type="act" value="Controlled Substances Act/s:102">section 102 of the Controlled Substances Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/21/802">21 U.S.C.
			 802</cato:entity-ref>)</cato:entity>);</text>
              </subparagraph>
              <subparagraph id="idadf8273e252448429a1eae7cd2aa5671">
                <enum>(B)</enum>
                <text>a biological product (as defined in <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                    <cato:entity-ref entity-type="act" value="Public Health Service Act/s:351">section 351 of the Public Health Service Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/262">
                    <cato:entity-ref entity-type="uscode" value="usc/42/262">42 U.S.C. 262</cato:entity-ref>
                  </external-xref>)</cato:entity>);</text>
              </subparagraph>
              <subparagraph id="id75570dda7f234c3e829b438b0d566821">
                <enum>(C)</enum>
                <text>an infused drug (including a peritoneal dialysis solution);</text>
              </subparagraph>
              <subparagraph id="ideabf91f7f74841f786682f63ae3721a2">
                <enum>(D)</enum>
                <text>an intravenously injected drug;</text>
              </subparagraph>
              <subparagraph id="ide7a9734353324f6d8331e683e162a9db">
                <enum>(E)</enum>
                <text>a drug that is inhaled during surgery;</text>
              </subparagraph>
              <subparagraph id="id648905d845a74e54bcfaa93e242bd1fd">
                <enum>(F)</enum>
                <text>a parenteral drug;</text>
              </subparagraph>
              <subparagraph id="id3c0f78d0181443d4a7c2a8c160ea3905">
                <enum>(G)</enum>
                <text>a drug manufactured through 1 or more biotechnology processes, including—</text>
                <clause id="id54eab55e3cfb46a0a96c165f8d97719f">
                  <enum>(i)</enum>
                  <text>a therapeutic DNA plasmid product;</text>
                </clause>
                <clause id="id0fc9db23d6d247d8926d79d5991989dd">
                  <enum>(ii)</enum>
                  <text>a therapeutic synthetic peptide product of not more than 40 amino acids;</text>
                </clause>
                <clause id="id5ca1aa42aa364b6f9d7609cf101019b7">
                  <enum>(iii)</enum>
                  <text>a monoclonal antibody product for in vivo use; and</text>
                </clause>
                <clause id="idc7ea61bbb38647f5819f57baef263b33">
                  <enum>(iv)</enum>
                  <text>a therapeutic recombinant DNA-derived product;</text>
                </clause>
              </subparagraph>
              <subparagraph id="id6cb89c156cd1434ea22d4bd19b1bb459">
                <enum>(H)</enum>
                <text>a drug required to be refrigerated at any time during manufacturing, packing, processing, or
			 holding; or</text>
              </subparagraph>
              <subparagraph id="id65f996a1442641a18a8af89e1a289d91">
                <enum>(I)</enum>
                <text>a photoreactive drug.</text>
              </subparagraph>
            </paragraph>
          </subsection>
          <subsection id="iddc557636ff9d466993f81250425c7b2f">
            <enum>(c)</enum>
            <header>Approved Canadian pharmacy</header>
            <paragraph id="ida5d18d015b99429f8db4ecf097c7852b">
              <enum>(1)</enum>
              <header>In general</header>
              <text>In this section, an approved Canadian pharmacy is a pharmacy that—</text>
              <subparagraph id="id477e7f1dca184031aaab95902cdf388c">
                <enum>(A)</enum>
                <text>is located in Canada; and</text>
              </subparagraph>
              <subparagraph id="ideb55d3b98ae042269e76f70a4fe19b76">
                <enum>(B)</enum>
                <text>that the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> certifies—</text>
                <clause id="id2053d0aed50d4ee2ae8cc0d1f1a4260f">
                  <enum>(i)</enum>
                  <text>is licensed to operate and dispense prescription drugs to individuals in Canada; and</text>
                </clause>
                <clause id="id093e331404fc442c91be4d484be185a2">
                  <enum>(ii)</enum>
                  <text>meets the criteria under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:810/ss:c/p:3" proposed="true">paragraph (3)</cato:entity-ref>.</text>
                </clause>
              </subparagraph>
            </paragraph>
            <paragraph id="id9d7eb12c74494581b465e723c69ed10e">
              <enum>(2)</enum>
              <header>Publication of approved canadian pharmacies</header>
              <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall publish on the Internet Web site of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7524" entity-type="federal-body">Food and Drug Administration</cato:entity-ref> a list of
			 approved Canadian pharmacies, including the Internet Web site address of
			 each such approved Canadian pharmacy, from which individuals may purchase
			 prescription drugs in accordance with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:810/ss:a" proposed="true">subsection (a)</cato:entity-ref>.</text>
            </paragraph>
            <paragraph id="id85cfc85f021c435bb406ff4e5bb7e09a">
              <enum>(3)</enum>
              <header>Additional criteria</header>
              <text>To be an approved Canadian pharmacy, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall certify that the pharmacy—</text>
              <subparagraph id="id12acaa80c34c42969e9110ea830613c7">
                <enum>(A)</enum>
                <text>has been in existence for a period of at least 5 years preceding the date of such certification and
			 has a purpose other than to participate in the program
			 established under this section;</text>
              </subparagraph>
              <subparagraph id="id6b391c716b7c4fffb90d41c3ca5eceea">
                <enum>(B)</enum>
                <text>operates in accordance with pharmacy standards set forth by the provincial pharmacy rules and
			 regulations enacted in Canada;</text>
              </subparagraph>
              <subparagraph id="id40e4c0202582445fbf5a33090e287cd1">
                <enum>(C)</enum>
                <text>has processes established by the pharmacy, or participates in another established process, to
			 certify that the physical premises and data reporting procedures and
			 licenses are in compliance with all applicable laws and regulations, and
			 has implemented policies designed to monitor ongoing compliance with such
			 laws and regulations;</text>
              </subparagraph>
              <subparagraph id="id9271d3f4ea46470ca6102c60ea557726">
                <enum>(D)</enum>
                <text>conducts or commits to participate in ongoing and comprehensive quality assurance programs and
			 implements such quality assurance measures, including blind testing, to
			 ensure the veracity and reliability of the findings of the quality
			 assurance program;</text>
              </subparagraph>
              <subparagraph id="id571531bf23a448df990976daabd442cd">
                <enum>(E)</enum>
                <text>agrees that laboratories approved by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall be used to conduct product testing to
			 determine the safety and efficacy of sample pharmaceutical products;</text>
              </subparagraph>
              <subparagraph id="idce04c7fb8cb34db8b46644264aae86c6">
                <enum>(F)</enum>
                <text>has established, or will establish or participate in, a process for resolving grievances and will
			 be held accountable for violations of established guidelines and rules;</text>
              </subparagraph>
              <subparagraph id="idbe2ef902f3af4333aba0839dea081669">
                <enum>(G)</enum>
                <text>does not resell products from online pharmacies located outside Canada to customers in the United
			 States; and</text>
              </subparagraph>
              <subparagraph id="id5e4c0a7901a346678603690f162f854e">
                <enum>(H)</enum>
                <text>meets any other criteria established by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>.</text>
              </subparagraph>
            </paragraph>
          </subsection>
        </section>
        <after-quoted-block>.</after-quoted-block>
      </quoted-block>
		</section>
  </legis-body>
</bill>
</doc>